Local drug delivery is simple to use and may conceivably in the future be delivered by the patients themselves, hence can be used as an adjunct to mechanical plaque removal.
Common Antibiotics : Used in periodontal therapy, easy approach for therapeut...DrUshaVyasBohra
An antibiotic is an agent that either kills or inhibits the growth of a microorganism.
The term antibiotic was first used in 1942 by Selman Waksman and his collaborators in journal articles to describe any substance produced by a microorganism that is antagonistic to the growth of other microorganisms in high dilution.[3] This definition excluded substances that kill bacteria but that are not produced by microorganisms (such as gastric juices and hydrogen peroxide). It also excluded synthetic antibacterial compounds such as the sulfonamides. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.
With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds.[4] These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. In accordance with this, many antibacterial compounds are classified on the basis of chemical/biosynthetic origin into natural, semisynthetic, and synthetic. Another classification system is based on biological activity; in this classification, antibacterials are divided into two broad groups according to their biological effect on microorganisms: Bactericidal agents kill bacteria, and bacteriostatic agents slow down or stall bacterial growth.Before the early 20th century, treatments for infections were based primarily on medicinal folklore. Mixtures with antimicrobial properties that were used in treatments of infections were described over 2000 years ago.[5] Many ancient cultures, including the ancient Egyptians and ancient Greeks, used specially selected mold and plant materials and extracts to treat infections.[6][7] More recent observations made in the laboratory of antibiosis between micro-organisms led to the discovery of natural antibacterials produced by microorganisms. Louis Pasteur observed, "if we could intervene in the antagonism observed between some bacteria, it would offer perhaps the greatest hopes for therapeutics". The term 'antibiosis', meaning "against life," was introduced by the French bacteriologist Jean Paul Vuillemin as a descriptive name of the phenomenon exhibited by these early antibacterial drugs.[9][10] Antibiosis was first described in 1877 in bacteria when Louis Pasteur and Robert Koch observed that an airborne bacillus could inhibit the growth of Bacillus anthracis. These drugs were later renamed antibiotics by Selman Waksman, an American microbiologist, in 1942. Synthetic antibiotic chemotherapy as a science and development of antibacterials began in Germany with Paul Ehrlich in the late 1880s. Ehrlich noted that certain.
Local drug delivery is simple to use and may conceivably in the future be delivered by the patients themselves, hence can be used as an adjunct to mechanical plaque removal.
Common Antibiotics : Used in periodontal therapy, easy approach for therapeut...DrUshaVyasBohra
An antibiotic is an agent that either kills or inhibits the growth of a microorganism.
The term antibiotic was first used in 1942 by Selman Waksman and his collaborators in journal articles to describe any substance produced by a microorganism that is antagonistic to the growth of other microorganisms in high dilution.[3] This definition excluded substances that kill bacteria but that are not produced by microorganisms (such as gastric juices and hydrogen peroxide). It also excluded synthetic antibacterial compounds such as the sulfonamides. Many antibacterial compounds are relatively small molecules with a molecular weight of less than 2000 atomic mass units.
With advances in medicinal chemistry, most modern antibacterials are semisynthetic modifications of various natural compounds.[4] These include, for example, the beta-lactam antibiotics, which include the penicillins (produced by fungi in the genus Penicillium), the cephalosporins, and the carbapenems. Compounds that are still isolated from living organisms are the aminoglycosides, whereas other antibacterials—for example, the sulfonamides, the quinolones, and the oxazolidinones—are produced solely by chemical synthesis. In accordance with this, many antibacterial compounds are classified on the basis of chemical/biosynthetic origin into natural, semisynthetic, and synthetic. Another classification system is based on biological activity; in this classification, antibacterials are divided into two broad groups according to their biological effect on microorganisms: Bactericidal agents kill bacteria, and bacteriostatic agents slow down or stall bacterial growth.Before the early 20th century, treatments for infections were based primarily on medicinal folklore. Mixtures with antimicrobial properties that were used in treatments of infections were described over 2000 years ago.[5] Many ancient cultures, including the ancient Egyptians and ancient Greeks, used specially selected mold and plant materials and extracts to treat infections.[6][7] More recent observations made in the laboratory of antibiosis between micro-organisms led to the discovery of natural antibacterials produced by microorganisms. Louis Pasteur observed, "if we could intervene in the antagonism observed between some bacteria, it would offer perhaps the greatest hopes for therapeutics". The term 'antibiosis', meaning "against life," was introduced by the French bacteriologist Jean Paul Vuillemin as a descriptive name of the phenomenon exhibited by these early antibacterial drugs.[9][10] Antibiosis was first described in 1877 in bacteria when Louis Pasteur and Robert Koch observed that an airborne bacillus could inhibit the growth of Bacillus anthracis. These drugs were later renamed antibiotics by Selman Waksman, an American microbiologist, in 1942. Synthetic antibiotic chemotherapy as a science and development of antibacterials began in Germany with Paul Ehrlich in the late 1880s. Ehrlich noted that certain.
”Contemporary Biomarkers In Periodontitis”- Guest lecture as a part of Dr NTRUHS Zonal CDE programme at Government Dental College and Hospital, Hyderabad, India on 281/1/2011, SIBAR Institute of Dental Sciences, Guntur, India on 29/12/12 and at Meghna Institute of Dental Sciences, Nizamabad, India on 31/7/2013.
Porphyromonas gingivalis belongs to the phylum Bacteroidetes and is a nonmotile, Gram-negative, rod-shaped, anaerobic, pathogenic bacterium. It forms black colonies on blood agar.
It is found in the oral cavity, where it is implicated in certain forms of periodontal disease, as well as in the upper gastrointestinal tract, the respiratory tract, and the colon. It has also been isolated from women with bacterial vaginosis. Collagen degradation observed in chronic periodontal disease results in part from the collagenase enzymes of this species. It has been shown in an in vitro study that P. gingivalis can invade human gingival fibroblasts and can survive in them in the presence of considerable concentrations of antibiotics.P. gingivalis also invades gingival epithelial cells in high numbers, in which cases both bacteria and epithelial cells survive for extended periods of time. High levels of specific antibodies can be detected in patients harboring P. gingivalis. Dr Harshavardhan Patwal , explains the various enzymes enzyme peptidyl-arginine deiminase, which is involved in citrullination.[4] Patients with rheumatoid arthritis have an increased incidence of periodontal disease, and antibodies against the bacterium are significantly more common in these patients.
P. gingivalis is divided into K-serotypes based upon capsular antigenicity of the various types.
Bruxism and its effect on periodontiumRamya Ganesh
Bruxism/teeth grinding is a common habit seen among pediatric patients and in older patients with relation to improper occlusion. This habit can cause extreme damage to facial muscles and TMJ. Various treatment options are available including botox injections. Hence as a dentist it is our duty to restore patient's oral health in harmony with other oro facial structures.
Biomarker is an objective measure that has been evaluated and confirmed either as an indicator of physiologic health, a pathogenic process or a pharmacologic response to a therapeutic intervention. Biomarkers, whether produces by normal healthy individuals or by individuals affected by specific systemic diseases, are tell tale molecules that could be used to monitor health status, disease onset, treatment response and outcome.The biomarkers can help for the determination of present as well as future disease activity along with diagnosis and previous periodontal diseases.
Antimicrobials in periodontics /certified fixed orthodontic courses by India...Indian dental academy
Welcome to Indian Dental Academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy has a unique training program & curriculum that provides students with exceptional clinical skills and enabling them to return to their office with high level confidence and start treating patients
State of the art comprehensive training-Faculty of world wide repute &Very affordable.
”Contemporary Biomarkers In Periodontitis”- Guest lecture as a part of Dr NTRUHS Zonal CDE programme at Government Dental College and Hospital, Hyderabad, India on 281/1/2011, SIBAR Institute of Dental Sciences, Guntur, India on 29/12/12 and at Meghna Institute of Dental Sciences, Nizamabad, India on 31/7/2013.
Porphyromonas gingivalis belongs to the phylum Bacteroidetes and is a nonmotile, Gram-negative, rod-shaped, anaerobic, pathogenic bacterium. It forms black colonies on blood agar.
It is found in the oral cavity, where it is implicated in certain forms of periodontal disease, as well as in the upper gastrointestinal tract, the respiratory tract, and the colon. It has also been isolated from women with bacterial vaginosis. Collagen degradation observed in chronic periodontal disease results in part from the collagenase enzymes of this species. It has been shown in an in vitro study that P. gingivalis can invade human gingival fibroblasts and can survive in them in the presence of considerable concentrations of antibiotics.P. gingivalis also invades gingival epithelial cells in high numbers, in which cases both bacteria and epithelial cells survive for extended periods of time. High levels of specific antibodies can be detected in patients harboring P. gingivalis. Dr Harshavardhan Patwal , explains the various enzymes enzyme peptidyl-arginine deiminase, which is involved in citrullination.[4] Patients with rheumatoid arthritis have an increased incidence of periodontal disease, and antibodies against the bacterium are significantly more common in these patients.
P. gingivalis is divided into K-serotypes based upon capsular antigenicity of the various types.
Bruxism and its effect on periodontiumRamya Ganesh
Bruxism/teeth grinding is a common habit seen among pediatric patients and in older patients with relation to improper occlusion. This habit can cause extreme damage to facial muscles and TMJ. Various treatment options are available including botox injections. Hence as a dentist it is our duty to restore patient's oral health in harmony with other oro facial structures.
Biomarker is an objective measure that has been evaluated and confirmed either as an indicator of physiologic health, a pathogenic process or a pharmacologic response to a therapeutic intervention. Biomarkers, whether produces by normal healthy individuals or by individuals affected by specific systemic diseases, are tell tale molecules that could be used to monitor health status, disease onset, treatment response and outcome.The biomarkers can help for the determination of present as well as future disease activity along with diagnosis and previous periodontal diseases.
Antimicrobials in periodontics /certified fixed orthodontic courses by India...Indian dental academy
Welcome to Indian Dental Academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy has a unique training program & curriculum that provides students with exceptional clinical skills and enabling them to return to their office with high level confidence and start treating patients
State of the art comprehensive training-Faculty of world wide repute &Very affordable.
The rationale for using antibiotics and chemotherapeutics in the periodontal disease treatment is its polymicrobial nature of disease. Antibiotic use should be done cautiously in treating various periodontal infection as improper use of it can lead to its resistance by bacterial strains. Antibiotic in periodontics is a very helpful adjunct in controlling the bacteria in the oral cavity
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
3. Objectives
• Chemotherapeutic agents in periodontal diseases.
• Contribution of Antimicrobials in Periodontal diseases.
• Brief knowledge of Antimicrobials used in Periodontal diseases.
7. • Antibiotics/Antimicrobial Agents
“Naturally occurring synthetic or semi synthetic type
of anti-infective agents that destroy or inhibits
the growth of selective micro-organism generally
at low concentration.”
8. • Antiseptic Agents
“Chemical antimicrobial agent applied topically
or sub-gingivally to mucous membrane wounds
or intact dermal surfaces to destroy micro-organism
or inhibit their reproduction or metabolism.”
10. SYSTEMIC ADMINISTRATION
• May be a necessary adjunct in controlling bacterial infection because bacteria
can invade periodontal tissues making mechanical therapy alone
sometimes ineffective.
• Antibiotics provide a useful adjunct to root planning, which by itself may
not remove all subgingival deposits and certainly would not affect any
invading organisms that had already penetrated the SOFT TISSUE.
11. Contribution of Antibiotics
• Systemic antimicrobials are released from the pocket wall into the GCF.
• The susceptibility of bacteria to the antibiotics may be the key to the efficacy
of systemic antibiotics in the treatment.
12. • Systemic antimicrobial therapy should be an adjunct to mechanical a
comprehensive periodontal treatment plan.
• The antibiotic required 500 times greater strength then systemic therapeutic
dose to be effective against the bacteria arranged in intact BIOFILMS
• It is therefore important to disrupt the biofilm physically.
13. Health
Oral hygiene
Root debridement
Supportive periodontal therapy
Surgical access for root debridement
Regenerative therapy
ANTIBIOTICS as indicated by microbial analysis
Aggressive, refractory or
medically related
periodontitis
Chronic
periodontitis
Microbial
analysis
IneffectiveEffective
Supportive periodontal treatment
Guideline for the use of antimicrobial therapy
14. INDICATIONS FOR ANTIBIOTICS IN
PERIODONTAL THERAPY
• local infection of a periodontal abscess can spread within tissue planes
to cause marked facial swelling and systemic involvement
• Acute Necrotizing Ulcerative Gingivitis ANUG
• Multiple abscess formation and gross periodontal infection
• Localized aggressive periodontitis LAP
15. IDEAL ANTIBIOTIC for periodontal disease
• Used in prevention & and treatment of periodontal disease
• Specific for periodontal pathogens
• Allogenic
• Non toxic
• Substantive
• Not in general use for treatment of other disease.
• inexpensive
17. So what????
• Oral bacteria are susceptible to many antibiotics.
• Unfortunately there is no single antibiotic i.e. (no “silver bullet”) at
concentration achieved in body fluids that inhibit all putative periodontal
pathogens.
• Indeed a combination of antibiotics may be necessary to eliminate
putative pathogens from periodontal pockets.
18. Selection of an ANTIBIOTIC
• Patients’ clinical status
• History of the disease
• Clinical signs & symptoms
• Radiographic aid
• Microbiologic sampling (if possible)
Plaque sampling is done by the help of paper points
19.
20. Common Antibiotics Regimens
Antimicrobial Agent Regimen Dosage/Duration
Amoxicillin 500mg TDS for 8 days
Azithromycin 500mg OD for 4-7 days
Ciprofloxacin 500mg BD for 8 days
Clindamycin 300mg TDS for 10 days
Doxycycline/minocycline 100-200mg OD for 21 days
Metronidazole 500mg TDS for 8 days
Metronidazole + Amoxicillin 250mg f each TDS for 8 days
Metronidazole + Ciprofloxacin 500mg of each BD for 8 days
21. TETRACYCLINES
Actisite , Robitet 500
• Produced from Streptomyces.
• Bacteriostatic.
• Protein synthesis inhibitor. (30s microsomal subunit)
• Effective against multiplying bacteria.
• Broad spectrum!! Activity against both Gram-positive and Gram negative
species
• Concentration In GCF is 2-10 times than in serum.
22. • Investigated as an important in adjunct in LAP
• Activity against A.actinomycetemcomitans
• Dual action!!! Antimicrobial + host modulation (inhibit Collagenase)
• So! Reduce bone destruction & Aid regeneration.
23. Minocycline [cinocid , cycloxin]
Adult periodontitis
Spirochetes & motile rods
200mg/day for 21 days
Less phototoxicity , renal toxicity than tetracycline.
Reversible vertigo is one of the side effect
24. Doxycycline
Similar spectrum as minocycline
Can be given OD so better compliance
100mg OD for 21 days.
Marked anti-collagenase effect.
Vibramycin 100mg
Nordox
Ardox
25. Metronidazole
• Nitromidazole compound
• Bactericidal
• Disrupt bacterial DNA synthesis.
• The antibacterial activity against anaerobic cocci,
anaerobic Gram - negative bacilli, and anaerobic Gram - positive
bacilli
Flagyl 400mg, 200mg
Gramex 400mg
26. • effective against A.actinomycetemcomitans in combination with other
antibiotics.
• Also effective against anaerobes such as porphyromonas gingivalis & provetella
intermedia
• Successfully used to treat ANUG
• Chronic periodontitis, aggressive periodontitis, clinically significant
gingivitis.
27. • 750-1000mg/day for 2 weeks reduces the anaerobic flora & decreases
histopathologic signs of periodontitis.
• Most common regimen is 250mg TDS for 7 days.
28. • Cramps , nausea , vomting results due to interaction with alcohol.
• Avoid alcohol.
• Inhibits warafrin metabolism so avoid in patients with anticoagulant
therapy.
• Avoid in patients taking LITHIUM
• Metallic taste.
31. 10% of the patients are resistant
to penicillin
32. Clindamycin
• Anaerobic bacteria.
• In case of penicillin allergy.
• Recommended dosage 150mg QDS for 10days.
300mg BD for 8 days.
• pseudomembranous colitis, diarrhea , GI upsets
33. Ciprofloxacin
Ciprox , ciclox
• Quinolones.
• Gram negative rods, all facultative & some anaerobic.
• It is the only antibiotic to which all strains of A.actinomycetemcomitans are
susceptible
• Nausea, metallic taste , abdominal discomfort
• 500mg BD for 8 days with or without Metronidazole.
34. Macrolides
• Bacteriostatic or bactericidal depending on concentration.
Erythromycin , Spiramycin
Azithromycin
Anaerobes , gram negative bacilli.
500mg OD for 4 -7 days
Zithromax
Zmax
Azomax 250mg
35. Serial & Combination Antibiotic Therapy
• Bacteriostatic antibiotic (e.g. tetracycline) require rapidly dividing
microorganism to be effective SO not function well if bactericidal antibiotic
(e.g. amoxicillin) is given concurrently. They are best given serially.
Metronidazole + Ciprofloxacin (POWERFULL COMBINATION)
effective against A.actinomycetemcomitans
Metronidazole against obligate anaerobes.
Ciprofloxacin against facultative anaerobes
36. Metronidazole + amoxicillin / Augmentin
Adult localized periodontitis , refractory to tetracyclines.
Additive effect against A.actinomycetemcomitans
250mg of each TDS for 8 days.
37. LOCAL ADMINISTRATION
• Local delivery antibiotics are recommended as adjuncts to scaling and root
debridement, and not as stand-alone treatments.
• Fewer side effects, and fewer chances of resistant bacteria forming
• The concentration of the antibiotic at the diseased site can be 100 times
greater than taking the medication orally i.e systemically.
38. Tetracycline containing fibers Actisite®
12.7 mg / 9 inches
Well tolerated , placed for 10 days
Concentration in GCF is 1300 Ugm/ml compared to 4-8mg by
sys. Administration.
41. Subgingival Minocycline
ARESTIN Small spheres of minocycline 2% , a derivative of tetracycline is
very effective in killing the bacteria that are thought to cause periodontal
disease